Our insights
By service
Supporting the patient doctor relationship – five top tips
Our last insight on this topic explored how patients have become more empowered as decision makers when it comes to their healthcare.
How the pharmacist has become a key decision maker
The role of the pharmacist in the pharma industry has evolved and their place in prescribing has accelerated. They are now key decision makers who need to be considered in pharma’s strategic approaches.
Are HCP education portals a thing of the past?
We believe there is very much a place for HCP education portals in driving understanding, building trust, and consented data, but wouldn’t be offering our clients balanced advice if we didn’t add our voice to the discussion.
Overcoming brand engagement strategy challenges
We know that brand engagement strategies come with their unique challenges, we do it every day.
The rise of the patient decision maker
There has been a significant shift regarding treatment decision making with patients having a far stronger voice than before, informed and advocating for themselves, they are attending appointments armed with a wealth of information. Here we explore the rise of the patient decision maker.
Why medical and commercial strategy should be aligned – but not identical
When it comes to pharma’s commercial and medical teams, there’s always healthy tension – but aligning strategy is important to ensure brand success.
Patient support programme for med device launch
Delivering effective patient support to ensure treatment plan adherence and the successful launch of a new medical device to the market.
5 reasons why omnichannel creates great engagement
Whether you call it omnichannel, or customer engagement, it is critical to achieving effective pharma marketing and brand optimisation.
Does outsourcing impact your brand?
As more pharma companies consider outsourcing teams to external partners, a natural question arises – does this strategy mean giving up your USP, what makes your brand unique in the marketplace?
Six reasons why outsourced sales teams succeed in pharma
As pharma companies seek new ways to optimise commercial investments, outsourced sales teams have emerged as an appealing strategy. But how will this impact pharma’s go-to-market models in the future?
The pharma brand trade-off – New product vs. mature brand investment
We understand the tough decisions being made and the trade-offs around promoting valuable mature brands vs. new products.
VPAG survey – Have your say
How is your company preparing for the 2024 VPAG changes, and what impact will the new agreement have? Take part in our survey.
